Heather A. Hirsch
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, Ovarian cancer diagnosis and treatment, PI3K/AKT/mTOR signaling in cancer, Cancer-related Molecular Pathways
Most-Cited Works
- → Preclinical Evaluation of the WEE1 Inhibitor MK-1775 as Single-Agent Anticancer Therapy(2013)169 cited
- → Phase I Trial of the Human Double Minute 2 Inhibitor MK-8242 in Patients With Advanced Solid Tumors(2017)125 cited
- → Characterization of immune regulatory molecules B7-H4 and PD-L1 in low and high grade endometrial tumors(2017)62 cited
- → MCL1 and BCL-xL Levels in Solid Tumors Are Predictive of Dinaciclib-Induced Apoptosis(2014)53 cited
- → Evaluating TBK1 as a Therapeutic Target in Cancers with Activated IRF3(2014)53 cited
- → ICONIC: Biologic and clinical activity of first in class ICOS agonist antibody JTX-2011 +/- nivolumab (nivo) in patients (pts) with advanced cancers.(2018)30 cited
- → The Retinoblastoma Tumor Suppressor Protein Targets Distinct General Transcription Factors To Regulate RNA Polymerase III Gene Expression(2000)28 cited
- → The Small Nuclear RNA-activating Protein 190 Myb DNA Binding Domain Stimulates TATA Box-binding Protein-TATA Box Recognition(2003)26 cited
- → Genes Coding for Tumor-specific Rejection Antigens(1994)15 cited
- → Handschuhperforationen bei gynäkologischen Operationen und abdominalen Schnittentbindungen(1992)13 cited